Phase Forward’s Safety Division President Chan Russell Named to PharmaVOICE 100 List

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Chan Russell, President of its Lincoln Technologies safety division has been named to the esteemed PharmaVOICE 100 list. Generated by PharmaVOICE readers, the list spotlights those individuals who have proven to be the most inspiring within the life-sciences industry.

MORE ON THIS TOPIC